Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2019-09-30 Regulatory Filings
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
본점소재지변경
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding a change in the company's registered office address (본점소재지변경). It provides specific details such as the old address, new address, reason for the change, and the effective date. Since this is a standard corporate regulatory disclosure that does not fit into specific categories like financial reports, dividends, or M&A, it falls under the general regulatory filing category.
2019-09-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This document specifically details changes in the company's board of directors, which falls under the category of Board/Management Information (MANG).
2019-09-30 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제8회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the acquisition of convertible bonds before maturity by HLB Life Science. It details the bond series, acquisition amount, reason for acquisition (cancellation), and funding source. This falls under capital structure changes and financing activities, specifically related to debt instruments, which is best classified as CAP (Capital/Financing Update).
2019-09-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제8회차)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from HLB Life Science regarding the acquisition of convertible bonds before maturity. It details the bond series, acquisition amount, acquisition date, and the reason for the acquisition (cancellation). This falls under capital structure changes and financing activities, specifically related to debt management, which is best classified as a Capital/Financing Update (CAP).
2019-09-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (HLB Co., Ltd.) in HLB Life Science Co., Ltd. due to the dissolution of a special relationship with a former executive. This falls under the category of Major Shareholding Notification.
2019-09-06 Korean
전환가액의조정(제8회차)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from HLB Life Science regarding the adjustment of the conversion price for its 8th series convertible bonds due to a decline in market price. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the category of capital and financing updates.
2019-08-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.